(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Alpha Cognition's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast ACOG's revenue for 2025 to be $160,598,365, with the lowest ACOG revenue forecast at $100,123,669, and the highest ACOG revenue forecast at $221,073,061. On average, 2 Wall Street analysts forecast ACOG's revenue for 2026 to be $505,584,478, with the lowest ACOG revenue forecast at $491,807,461, and the highest ACOG revenue forecast at $519,361,495.
In 2027, ACOG is forecast to generate $1,451,392,702 in revenue, with the lowest revenue forecast at $1,451,392,702 and the highest revenue forecast at $1,451,392,702.